Switzerland · Who invested in Arvelle Therapeutics?
Arvelle Therapeutics's investors include Andera Partners, LSP, KB Investment, EQT Life Sciences and BRV, and 2 more on record.
2020
$180MSeries A$43MSeries A
Switzerland · Series A startup
Who invested in Arvelle Therapeutics
Funding summaryUpdated 26 Oct 2026
$223Mraised across 2 rounds since 2019, from 2 sources
$180MSeries A$43MSeries A
- Latest round
- Series A, $43MMay 2020
- Biggest round
- $180MSeries A · Feb 2019
- Investors
- 7 (1 led)
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $180M Feb 2019
- Biggest round
- $180M Series A · Feb 2019
- Between rounds
- 14 months from the last two
The rounds
- May 2020
- Feb 2019Series A$180M5 new
- LSPLead
Andera Partners- BRV
- H.I.G. BioHealth
- LSP/ NovaQuest
Reported by European-biotechnology
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series A2019Series A2020Andera PartnersLSPL
KB Investment
EQT Life SciencesBRVH.I.G. BioHealthLSP/ NovaQuest
Andera PartnersLSPLKB InvestmentEQT Life SciencesBRVH.I.G. BioHealthLSP/ NovaQuestEveryone who backed them
LSPGrowth equity1round, led 1
BRVInvestment firm1round
H.I.G. BioHealthVC firm1round
LSP/ NovaQuestno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Arvelle Therapeutics
How much has Arvelle Therapeutics raised?
Arvelle Therapeutics has raised $223M across 2 rounds since 2019.
When did Arvelle Therapeutics last raise?
Arvelle Therapeutics's most recent round was a Series A of $43M in May 2020.
What was Arvelle Therapeutics's biggest round?
Arvelle Therapeutics's largest round on record is $180M (Series A), in Feb 2019, led by LSP.
Who backed Arvelle Therapeutics first?
Arvelle Therapeutics's first round on record, in Feb 2019, was backed by LSP, Andera Partners and BRV and 2 others.
What stage is Arvelle Therapeutics at?
Arvelle Therapeutics's latest named round is a Series A, in May 2020.
Where is Arvelle Therapeutics based?
Arvelle Therapeutics is based in Switzerland.
Who led Arvelle Therapeutics's rounds?
LSP led the Series A in 2019.
Companies like Arvelle Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.